Singular Genomics Systems Inc
NASDAQ:OMIC
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Singular Genomics Systems Inc
Current Portion of Long-Term Debt
Singular Genomics Systems Inc
Current Portion of Long-Term Debt Peer Comparison
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/tmo.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/dhr.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/mtd.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/a.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/iqv.png)
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Singular Genomics Systems Inc
NASDAQ:OMIC
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
Current Portion of Long-Term Debt
$4.5B
|
CAGR 3-Years
936%
|
CAGR 5-Years
27%
|
CAGR 10-Years
7%
|
![]() |
Danaher Corp
NYSE:DHR
|
Current Portion of Long-Term Debt
$1.7B
|
CAGR 3-Years
459%
|
CAGR 5-Years
116%
|
CAGR 10-Years
39%
|
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
Current Portion of Long-Term Debt
$183.2m
|
CAGR 3-Years
52%
|
CAGR 5-Years
28%
|
CAGR 10-Years
27%
|
![]() |
Agilent Technologies Inc
NYSE:A
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
Current Portion of Long-Term Debt
$717m
|
CAGR 3-Years
71%
|
CAGR 5-Years
48%
|
CAGR 10-Years
46%
|